Showing results (131-140 of 160) with videos related to
Sort By:
Pageof 16
Australian and New Zealand Journal of Medicine|February 1, 1983
Lorazepam as an adjunct to antiemetic therapy with haloperidol in patients receiving cytotoxic chemotherapyM L Friedlander, J H Kearsley, K Sims, et al.Cancer Treatment Reports|February 1, 1987
Mitomycin and mitoxantrone in previously treated patients with advanced breast cancerJ F Bishop, D Raghavan, R Woods, et al.European Journal of Cancer & Clinical Oncology|November 1, 1987
Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimensS T Milliken, M H Tattersall, R L Woods, et al.The Journal of Urology|September 1, 1991
Benign prostatic hyperplasia--video image analysis and its relationship to androgen and epidermal growth factor receptor expressionM Frydenberg, T M Foo, A S Jones, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Translational studies of glutathione in bladder cancer cell lines and human specimensL Pendyala, S Velagapudi, K Toth, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1990
Effective salvage chemotherapy with etoposide, dactinomycin, and methotrexate in refractory germ cell cancer. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, V Harvey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1997
Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group studyS B Saxman, K J Propert, L H Einhorn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1988
A prospective study of cisplatin-based combination chemotherapy in advanced germ cell malignancy: role of maintenance and long-term follow-upJ A Levi, D Thomson, T Sandeman, et al.British Journal of Urology|June 1, 1988
Surveillance for stage I non-seminomatous germ cell tumours of the testis: the optimal protocol has not yet been definedD Raghavan, B Colls, J Levi, et al.European Journal of Cancer & Clinical Oncology|July 1, 1989
Dose intensity and outcome with combination chemotherapy for germ cell carcinoma. Australasian Germ Cell Trial GroupJ A Levi, D Thomson, J Bishop, et al.Pageof 16